2019: Professor Sir Stephen O’Rahilly, MD, Co-Director, Wellcome Trust-MRC Institute of Metabolic Science, Professor of Clinical Biochemistry and Medicine, University of Cambridge, for paradigm-shifting work on the genetic causes of obesity and its adverse effect on metabolic health.
2017: Stephen L. Hauser, M.D., director of the UCSF Weill Institute for Neurosciences and professor and chair of the Department of Neurology at the University of California, San Francisco, for discoveries that paved the way for a highly effective drug in the treatment of MS.
2016: Suzanne L. Topalian, M.D. of Johns Hopkins University School and Jedd D. Wolchok, M.D., Ph.D. of Memorial Sloan Kettering Cancer Center, for their contributions to immunotherapy as a new paradigm in the
treatment of advanced cancers.
2015: Mahlon DeLong, M.D., of Emory University, for his contributions to the treatment of Parkinson’s disease.
2014: Carl June, M.D., of the Perelman School of Medicine at the University of Pennsylvania, for discoveries relatedto immunotherapy for leukemia using patients’ own T cells.
2013: Brian Druker, M.D., of the Oregon Health & Science University and Charles Sawyers, M.D., of Memorial SloanKettering Cancer Center, for their discoveries related to chronic myeloid leukemia.
2012: Hal Dietz, M.D., of Johns Hopkins University for his discoveries related to connective tissue disease.